Renin–angiotensin system agents, diuretics, antiplatelet agents, calcium channel blockers, beta blockers, glucose-lowering drugs (excluding insulins) and magnesium were among the most prescribed drugs in CKD patients, a finding observed throughout all CKD stages. Here, INS is linked to chronic kidney disease.